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 Clinical biochemistry and pathology have contributed too many assays for diagnosis 
and prognosis of human health and diseases. Bedside biochemistry has revolutionized modern 
medicine and the invention of new generation biosensors have educated the patients like never 
before. Although, there are many gadgets which are available for monitoring the blood glucose 
in the patients with metabolic syndromes, hardly any assays can accurately predict and aid 
in early detection of metabolic syndrome. By the time a person is diagnosed and treated for 
metabolic syndrome, molecular and pathological damages further push the patient towards the 
metabolic syndrome. Early detection and early treatments are necessary to further revolutionize 
the field of Medicine.
 Metabolic syndrome is not a completely solved riddle, there are several factors which 
contribute towards the genesis and progression of the disease. Energy metabolism is in the 
center of metabolic syndrome, and mitochondria are one such organelle where majority of the 
energy metabolism takes place. Given that it is at the center of energy metabolism, most of 
the proteins required for this process are supplied by the nuclear gene products. Additionally, 
the mitochondria with its genome is responsible for 13 of the key electron transport com-
plex proteins. Mutations in both nuclear and mitochondrial genes result in Mitochondrial En-
cephalomyopathy Lactic Acidosis and Stroke-like Episodes (MELAS), Myoclonic Epilepsy 
and Ragged-Red Fiber Disease (MERF), Mitochondrial Neurogastrointestinal Encephalopathy 
(MNGIE) and Leigh syndrome.
 The mitochondrial genome is a simple closed circular molecule that contains 16,569 
DNA base pairs compared to the complex nuclear genome. But on the other hand, the nuclear 
genome has specified amount i.e., two copies at the least of every gene and the quality of the ge-
nome is well maintained by “well-oiled” DNA repair machinery. In mitochondrial genome con-
tains numerous copies of the genes. Apart from this the number of mitochondria in each tissue 
also varies. This imbalance in quantity of proteins generated from mitochondria and nucleus for 
electron transport complex is a testimony of their importance in energy metabolism. Mitochon-
drial DNA (mtDNA) quantity and the quality is an important aspect of the energy metabolism. 
The factors attributing towards determining the number of mitochondria and mitochondrial 
DNA copy number is yet unclear. Nonetheless, recent investigations suggest a negative correla-
tion between mitochondrial DNA copy number and disease process and progression. A recent 
article Reznik et al1 clearly demonstrated the correlation between mtDNA copy number to 
the expression of mitochondrially-localized metabolic pathways, suggesting that mtDNA copy 
number variation reflects gross changes in mitochondrial metabolic activity. As we discussed 
the significance of the mitochondrial DNA copy number, it is also important to note the qual-
ity of the DNA, it is observed that over a period of time the bad copies of the mitochondrial 
DNA accumulate within tissue mitochondria as the mitochondrial DNA repair mechanism is 
not as effective as the nuclear DNA repair mechanisms and the chances of mutation at the end 
of every replication cycle is higher. With this delicate balance of the quality and quantity of the 
mtDNA determining the efficacy of the energy metabolism, there is a high possibility that these 
changes can be used as indicators of the metabolic problems to occur in near future. It is up to 
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the scientific communities to decide whether it is time for us to seriously investigate the numerical relation of mitochondrial DNA 
copy number as a health indicator. Appropriate detection of mtDNA mutations and quantification of mtDNA can be a very important 
means in the resources of the modern day physicians.
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